Profound Medical (PROF) Competitors $7.02 +0.04 (+0.57%) (As of 02:02 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PROF vs. AXGN, AVNS, IRMD, BFLY, SMLR, SIBN, KIDS, TMCI, NNOX, and TCMDShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include AxoGen (AXGN), Avanos Medical (AVNS), Iradimed (IRMD), Butterfly Network (BFLY), Semler Scientific (SMLR), SI-BONE (SIBN), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Nano-X Imaging (NNOX), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. Profound Medical vs. AxoGen Avanos Medical Iradimed Butterfly Network Semler Scientific SI-BONE OrthoPediatrics Treace Medical Concepts Nano-X Imaging Tactile Systems Technology AxoGen (NASDAQ:AXGN) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings. Is AXGN or PROF more profitable? AxoGen has a net margin of -7.91% compared to Profound Medical's net margin of -349.41%. AxoGen's return on equity of -14.91% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-7.91% -14.91% -7.49% Profound Medical -349.41%-85.22%-64.87% Which has higher earnings & valuation, AXGN or PROF? AxoGen has higher revenue and earnings than Profound Medical. AxoGen is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$159.01M4.71-$21.72M-$0.32-53.13Profound Medical$8.98M23.66-$28.57M-$1.34-5.28 Does the MarketBeat Community prefer AXGN or PROF? AxoGen received 413 more outperform votes than Profound Medical when rated by MarketBeat users. However, 72.73% of users gave Profound Medical an outperform vote while only 72.71% of users gave AxoGen an outperform vote. CompanyUnderperformOutperformAxoGenOutperform Votes45372.71% Underperform Votes17027.29% Profound MedicalOutperform Votes4072.73% Underperform Votes1527.27% Does the media favor AXGN or PROF? In the previous week, AxoGen had 4 more articles in the media than Profound Medical. MarketBeat recorded 6 mentions for AxoGen and 2 mentions for Profound Medical. AxoGen's average media sentiment score of 0.80 beat Profound Medical's score of -0.24 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, AXGN or PROF? AxoGen has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Do insiders and institutionals hold more shares of AXGN or PROF? 80.3% of AxoGen shares are owned by institutional investors. Comparatively, 47.9% of Profound Medical shares are owned by institutional investors. 7.0% of AxoGen shares are owned by insiders. Comparatively, 1.5% of Profound Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer AXGN or PROF? AxoGen presently has a consensus price target of $15.00, indicating a potential downside of 11.76%. Profound Medical has a consensus price target of $13.75, indicating a potential upside of 94.21%. Given Profound Medical's stronger consensus rating and higher probable upside, analysts plainly believe Profound Medical is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Profound Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 SummaryAxoGen beats Profound Medical on 13 of the 19 factors compared between the two stocks. Ad Insiders ExposedMysterious drone activity triggers massive 1,366% surgeIf mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.👉 Click here now to see how this signal works. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$209.60M$4.43B$5.24B$9.28BDividend YieldN/A44.58%5.12%4.28%P/E Ratio-5.2124.9887.5417.25Price / Sales23.3353.991,164.33121.12Price / CashN/A43.4043.3837.82Price / Book5.457.174.844.94Net Income-$28.57M$14.01M$121.05M$225.76M7 Day Performance-4.12%4.60%2.49%3.92%1 Month Performance-10.97%-0.38%17.57%1.71%1 Year Performance-23.04%36.81%28.57%15.79% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical1.7973 of 5 stars$7.02+0.6%$13.75+95.9%-23.7%$210.80M$8.98M-5.24150AXGNAxoGen1.7595 of 5 stars$17.02+8.8%$15.00-11.9%+132.3%$749.02M$180.86M-53.19426Short Interest ↓News CoveragePositive NewsGap UpAVNSAvanos Medical3.2826 of 5 stars$15.92-1.0%N/A-29.7%$731.64M$681.50M46.823,771News CoverageIRMDIradimed4.5475 of 5 stars$54.02-1.2%$60.00+11.1%+17.0%$684.60M$71.31M37.00110Short Interest ↑BFLYButterfly Network0.6404 of 5 stars$3.01-2.6%$3.00-0.3%+193.4%$641.32M$76.22M-6.54460Short Interest ↑SMLRSemler Scientific1.3577 of 5 stars$61.39-0.6%N/A+65.0%$568.90M$58.94M29.9592SIBNSI-BONE4.3244 of 5 stars$13.15-0.8%$23.00+74.9%-36.9%$551.49M$157.04M-14.29350KIDSOrthoPediatrics4.0747 of 5 stars$22.52+0.6%$39.00+73.2%-36.2%$545.34M$189.67M-18.31200TMCITreace Medical Concepts1.6466 of 5 stars$6.88-1.1%$7.88+14.5%-42.5%$428.60M$202.86M-6.95250NNOXNano-X Imaging1.8809 of 5 stars$7.13+5.5%$12.00+68.3%+5.5%$411.96M$10.68M-8.39190TCMDTactile Systems Technology3.5917 of 5 stars$16.87-0.8%$23.00+36.3%+20.8%$404.83M$285.05M25.95980 Related Companies and Tools Related Companies AXGN Competitors AVNS Competitors IRMD Competitors BFLY Competitors SMLR Competitors SIBN Competitors KIDS Competitors TMCI Competitors NNOX Competitors TCMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PROF) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored“AI Killer” 10x More Powerful Than ChatGPTElon Musk may be about to “kill” the world’s most powerful AI. Very few people are talking about the one AI...Paradigm Press | SponsoredThere’s One Thing Trump and Musk Can’t FixDonald Trump and Elon Musk are teaming up to fix America's broken government. With the launch of the Depart...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
